Latest News
Below are all of the latest news articles relating to
CXR Biosciences. Click on a news headline to read the full article:
| CXR Biosciences is a partner in a ten million Euro R&D project “ScreenTox” that has been selected for funding by the HEALTH Programme of the European Commission and by COLIPA
Monday 7.6.10
CXR Biosciences Ltd today announced they will be joining with other partners in a five year joint research and development project which is now entering negotiations to receive funding within the Health Programme of the European Commission's 7th RTD Framework Programme.
|
| Non-genotoxic carcinogenicity study accepted for publication by leading scientific journal
Monday 24.5.10
CXR Biosciences Ltd and TaconicArtemis GmbH are pleased to announce that the prestigious Toxicological Sciences Journal has accepted for publication a manuscript which demonstrates the utility of the transgenic ADME mice (transADMET™)
|
| Studies Using CXR and Taconic HRN™ Mouse Featured at North American Regional ISSX Meeting
Wednesday 31.3.10
Results of studies using CXR’s and it’s partner Taconic's novel HRN™ (Hepatic Reductase Null) mouse were presented at the 16th North American Regional ISSX Meeting.
|
| CXR Biosciences Co-Founder Awarded Prestigious Risk Assessment Award at SOT
Monday 29.3.10
Dr. Cliff Elcombe, Director of Research and Co-Founder of CXR Biosciences Ltd, has been awarded “The Best Presentation in Risk Assessment” at the Annual Meeting of the Society of Toxicology (SOT) in Salt Lake City.....
|
| CXR and Taconic announce launch of transADMET program, Taconic establishes unit in Edinburgh, Scotland
Tuesday 9.2.10
TaconicArtemis GmbH has been working with CXR to deliver novel, commercially viable, models that are more predictive of the pharmacokinetic and toxicological effects of candidate drug compounds and their metabolites in the human body.
|
| CXR Biosciences CSO and Co-Founder Awarded OBE
Thursday 21.1.10
Professor Roland Wolf, Chief Scientific Officer and Co-Founder of CXR Biosciences Ltd, has been awarded an OBE in the UK New Year’s Honours list in recognition of his services to science.
|
| Millipore Corporation and CXR Biosciences Introduce Toxicity Reporter Assay Panel
Friday 13.3.09
Millipore Corporation (Billerica, MA) and CXR Biosciences® (Dundee, UK) today launched ToxReporter™, a new panel of engineered cell lines and assays that can screen compounds for toxicity early in the drug discovery process.
|
| ITI research programme recognised with important publication
Monday 4.8.08
Research carried out by ITI Life Sciences, CXR Biosciences and TaconicArtemis GmbH published in the prestigious Journal of Clinical Investigation
|
| CXR Biosciences and Millipore Corporation Launch New Antibody Panel
Tuesday 15.7.08
New CYP450 Antibody Panel has Utility in Drug Discovery and Toxicological Analysis
|
| CXR Biosciences Validates Impact of INGENUITY's IPA 5.0
Saturday 19.4.08
CXR announces a collaboration with Ingenuity Systems to improve and validate IPA-Tox™, a pathways driven molecular toxicology tool for investigative toxicology.....
|
Page
1 2
3
4
Next
|
CXR Biosciences is a partner in a ten million Euro R&D ..
